<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141653784326250%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201903026%26RESULT%3d1%26SIGN%3d61Or4QmXRt3G7FAazsJ1NWkw4cw%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201903026&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201903026&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201903026&amp;v=MDkzNTRqbFZMeklQVFhNWmJHNEg5ak1ySTlIWW9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#48" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#49" data-title="1.1 研究对象">1.1 研究对象</a></li>
                                                <li><a href="#51" data-title="1.2 治疗">1.2 治疗</a></li>
                                                <li><a href="#53" data-title="1.3 指标检测">1.3 指标检测</a></li>
                                                <li><a href="#62" data-title="1.4 统计学处理">1.4 统计学处理</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#65" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#66" data-title="2.1 两组治疗前后心功能比较">2.1 两组治疗前后心功能比较</a></li>
                                                <li><a href="#68" data-title="2.2 两组治疗前后的血脂水平比较">2.2 两组治疗前后的血脂水平比较</a></li>
                                                <li><a href="#74" data-title="2.3 两组治疗前后的血清TNF-α、TRAIL水平及生活质量比较">2.3 两组治疗前后的血清TNF-α、TRAIL水平及生活质量比较</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#77" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#70" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;两组治疗前后的心功能比较&lt;/b&gt;&lt;mathml id=&quot;71&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>1 <b>两组治疗前后的心功能比较</b><mathml id="71"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                                <li><a href="#72" data-title="&lt;b&gt;表&lt;/b&gt;2 &lt;b&gt;两组治疗前后的血脂水平比较&lt;/b&gt;&lt;mathml id=&quot;73&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt; (&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo stretchy=&quot;false&quot;&gt;) &lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>2 <b>两组治疗前后的血脂水平比较</b><mathml id="73"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml></a></li>
                                                <li><a href="#76" data-title="&lt;b&gt;表&lt;/b&gt;3 &lt;b&gt;两组治疗前后&lt;/b&gt;TNF-α、TRAIL&lt;b&gt;水平和生活质量比较&lt;/b&gt;"><b>表</b>3 <b>两组治疗前后</b>TNF-α、TRAIL<b>水平和生活质量比较</b></a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="朱春频.他汀类药物治疗冠心病合并高脂血症的效果分析[J].中西医结合心脑血管病杂志, 2012, 10 (2) :144." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYYY201202013&amp;v=MDc5OTlLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpsVkx6SVB6VFNkN0c0SDlQTXJZOUVaNFE=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        朱春频.他汀类药物治疗冠心病合并高脂血症的效果分析[J].中西医结合心脑血管病杂志, 2012, 10 (2) :144.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="王丽美, 许军芳, 陈文静, 王锐霞, 张娜.复方丹参滴丸联合阿托伐他汀治疗冠心病并高脂血症的疗效分析[J].中国临床保健杂志, 2015, 14 (5) :489-492." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=LZBJ201505013&amp;v=MjYwODNVUjdxZlp1Wm1GeWpsVkx6SUtUZkpaTEc0SDlUTXFvOUVaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckM=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        王丽美, 许军芳, 陈文静, 王锐霞, 张娜.复方丹参滴丸联合阿托伐他汀治疗冠心病并高脂血症的疗效分析[J].中国临床保健杂志, 2015, 14 (5) :489-492.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title="彭艳.复方丹参滴丸联合瑞舒伐他汀治疗冠心病合并高脂血症患者的临床疗效[J].世界最新医学信息文摘, 2015, 15 (24) :138-139." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=WMIA201524109&amp;v=Mjc0MjhIOVRPcTQ1RmJZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTHpJTWlEQ2I3RzQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        彭艳.复方丹参滴丸联合瑞舒伐他汀治疗冠心病合并高脂血症患者的临床疗效[J].世界最新医学信息文摘, 2015, 15 (24) :138-139.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="刘芳芳.肿瘤坏死因子相关凋亡诱导配体及其受体DR5对动脉粥样硬化斑块形成的影响[D].济南:山东大学, 2014." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CDFD&amp;filename=1014310240.nh&amp;v=MDYwMjFIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZMeklWRjI2R3JDNUh0UElyNUViUElRS0Q=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                        刘芳芳.肿瘤坏死因子相关凋亡诱导配体及其受体DR5对动脉粥样硬化斑块形成的影响[D].济南:山东大学, 2014.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="齐玲, 赵东海, 王玮瑶, 等.Caspase-8和Bcl-2在脑肿瘤干细胞肿瘤坏死因子相关凋亡诱导配体耐药中的作用研究[J].中国药学杂志, 2015, 50 (2) :152-156." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYX201502015&amp;v=MTgxNDVSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpsVkx6SVB5clNkckc0SDlUTXJZOUVZWVFLREg4NHY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                        齐玲, 赵东海, 王玮瑶, 等.Caspase-8和Bcl-2在脑肿瘤干细胞肿瘤坏死因子相关凋亡诱导配体耐药中的作用研究[J].中国药学杂志, 2015, 50 (2) :152-156.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title="钱茜.阿托伐他汀治疗老年冠心病合并高脂血症临床研究[J].中国现代药物应用, 2013, 7 (10) :72-73." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZWYY201310060&amp;v=MDgzMTh0R0ZyQ1VSN3FmWnVabUZ5amxWTHpJUHpyU2Q3RzRIOUxOcjQ5RFpJUUtESDg0dlI0VDZqNTRPM3pxcUI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[6]</b>
                                        钱茜.阿托伐他汀治疗老年冠心病合并高脂血症临床研究[J].中国现代药物应用, 2013, 7 (10) :72-73.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" title="宋勇宏.阿托伐他汀在老年冠心病合并高脂血症中的应用分析[J].中国当代医药, 2013, 20 (15) :65-66." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGUD201315035&amp;v=MDMzMzJPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTHpJUHlyZWFyRzRIOUxOcW85R1lZUUtESDg0dlI0VDZqNTQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[7]</b>
                                        宋勇宏.阿托伐他汀在老年冠心病合并高脂血症中的应用分析[J].中国当代医药, 2013, 20 (15) :65-66.
                                    </a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="吴法令.阿托伐他汀治疗老年冠心病合并高脂血症的临床分析[J].现代诊断与治疗, 2013, 24 (3) :627-628." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XDZD201303110&amp;v=MDI1NzZWTHpJUFNuUmFyRzRIOUxNckk1RVpJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amw=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                        吴法令.阿托伐他汀治疗老年冠心病合并高脂血症的临床分析[J].现代诊断与治疗, 2013, 24 (3) :627-628.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" >
                                        <b>[9]</b>
                                    陈树彤, 史培杰, 黄电波, 等.复方丹参滴丸治疗冠心病合并高脂血症疗效观察[C].复方丹参滴丸美国FDAII期临床试验结果报告暨第四届学术研讨会论文集.2010:183-185.</a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="刘清安.辛伐他汀 (舒降之) 联合复方丹参滴丸治疗冠心病合并高脂血症102例临床分析[J].医学理论与实践, 2012, 25 (13) :1583-1584." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YXLL201213022&amp;v=MzI1MTdMeklQRFhIWXJHNEg5UE5ySTlIWm9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        刘清安.辛伐他汀 (舒降之) 联合复方丹参滴丸治疗冠心病合并高脂血症102例临床分析[J].医学理论与实践, 2012, 25 (13) :1583-1584.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="许玲.复方丹参滴丸联合瑞舒伐他汀治疗冠心病合并高脂血症患者的临床疗效[J].中国循证心血管医学杂志, 2014, 7 (1) :99-101." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PZXX201401045&amp;v=MDAwMDVyRzRIOVhNcm85QllZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTHpJTlRmVGQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        许玲.复方丹参滴丸联合瑞舒伐他汀治疗冠心病合并高脂血症患者的临床疗效[J].中国循证心血管医学杂志, 2014, 7 (1) :99-101.
                                    </a>
                                </li>
                                <li id="27">


                                    <a id="bibliography_12" title="纪佳.复方丹参滴丸对高血脂患者血液流变学的影响[J].中国当代医药, 2013, 6 (8) :117-118, 120." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGUD201308064&amp;v=MTI1MDdUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZMeklQeXJlYXJHNEg5TE1wNDlEWUlRS0RIODR2UjQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                        纪佳.复方丹参滴丸对高血脂患者血液流变学的影响[J].中国当代医药, 2013, 6 (8) :117-118, 120.
                                    </a>
                                </li>
                                <li id="29">


                                    <a id="bibliography_13" title="林大梁, 林先锋, 袁小兰.复方丹参滴丸治疗冠心病的临床分析[J].数理医药学杂志, 2013, 26 (1) :82-83." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SLYY201301032&amp;v=MTg1NjdUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZMeklOaUhTZDdHNEg5TE1ybzlHWm9RS0RIODR2UjQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                        林大梁, 林先锋, 袁小兰.复方丹参滴丸治疗冠心病的临床分析[J].数理医药学杂志, 2013, 26 (1) :82-83.
                                    </a>
                                </li>
                                <li id="31">


                                    <a id="bibliography_14" title="任满意, 张运, 隋树建, 等.肿瘤坏死因子相关的凋亡诱导配体及其死亡受体5与急性冠状动脉综合征的关系[J].中国动脉硬化杂志, 2007, 15 (11) :842-846." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=KDYZ200711011&amp;v=MjkxNTlJTGluU2RMRzRIdGJOcm85RVpZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTHo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[14]</b>
                                        任满意, 张运, 隋树建, 等.肿瘤坏死因子相关的凋亡诱导配体及其死亡受体5与急性冠状动脉综合征的关系[J].中国动脉硬化杂志, 2007, 15 (11) :842-846.
                                    </a>
                                </li>
                                <li id="33">


                                    <a id="bibliography_15" title="刘利宁.急性脑梗死患者血清TRAIL、OPG测定及其临床意义的研究[D].兰州:兰州大学, 2011." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CMFD&amp;filename=1011142646.nh&amp;v=MDYwOTR6cXFCdEdGckNVUjdxZlp1Wm1GeWpsVkx6SVZGMjZIN0s4SE5mSXFaRWJQSVFLREg4NHZSNFQ2ajU0TzM=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[15]</b>
                                        刘利宁.急性脑梗死患者血清TRAIL、OPG测定及其临床意义的研究[D].兰州:兰州大学, 2011.
                                    </a>
                                </li>
                                <li id="35">


                                    <a id="bibliography_16" >
                                        <b>[16]</b>
                                    白景瑞.清热解毒方与凉血活血方防治术后腹腔粘连的实验研究[D].天津:天津医科大学, 2016.</a>
                                </li>
                                <li id="37">


                                    <a id="bibliography_17" title="李响, 吴振起, 马雪涛, 等.注射用血栓通对大鼠血管内皮细胞凋亡机制的影响[J].中华中医药杂志, 2010, 25 (7) :1137-1139." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=BXYY201007059&amp;v=MDk4NDNTZDdHNEg5SE1xSTlBYllRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZMeklKelg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[17]</b>
                                        李响, 吴振起, 马雪涛, 等.注射用血栓通对大鼠血管内皮细胞凋亡机制的影响[J].中华中医药杂志, 2010, 25 (7) :1137-1139.
                                    </a>
                                </li>
                                <li id="39">


                                    <a id="bibliography_18" title="华新宇, 王晓兰, 康美清, 等.三七总皂苷对慢性心力衰竭患者心功能及血浆细胞凋亡相关因子的影响[J].中国中医急症, 2014, 23 (12) :2368-2370." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYJZ201412095&amp;v=MDE1NzFOclk5TVlZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTHpJUHpUQmRMRzRIOVg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[18]</b>
                                        华新宇, 王晓兰, 康美清, 等.三七总皂苷对慢性心力衰竭患者心功能及血浆细胞凋亡相关因子的影响[J].中国中医急症, 2014, 23 (12) :2368-2370.
                                    </a>
                                </li>
                                <li id="41">


                                    <a id="bibliography_19" title="Schoppet M, Sattler AM, Schaefer JR, et al.Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis[J].Atherosclerosis, 2006, 184 (2) :446-447." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011601333593&amp;v=MjQxMDVIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJRjRUYVJJPU5pZk9mYks3SHRETnFZOUVaK2dNQ1hVNm9CTVQ2VDRQUQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[19]</b>
                                        Schoppet M, Sattler AM, Schaefer JR, et al.Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis[J].Atherosclerosis, 2006, 184 (2) :446-447.
                                    </a>
                                </li>
                                <li id="43">


                                    <a id="bibliography_20" title="Morel J, Audo R, Hahne M, et al.Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol3kinase/Akt[J].J Biol Chem, 2005, 280 (16) :15709-15718." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt">
                                        <b>[20]</b>
                                        Morel J, Audo R, Hahne M, et al.Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol3kinase/Akt[J].J Biol Chem, 2005, 280 (16) :15709-15718.
                                    </a>
                                </li>
                                <li id="45">


                                    <a id="bibliography_21" title="王素云, 王海芸, 黄晓燕, 等.阿托伐他汀对大鼠缺血心肌TRAIL表达及细胞凋亡的影响[J].温州医学院学报, 2012, 42 (4) :317-321." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=WZYX201204005&amp;v=MjUzNDg2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpsVkx6SU1qZlNkckc0SDlQTXE0OUZZWVFLREg4NHZSNFQ=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[21]</b>
                                        王素云, 王海芸, 黄晓燕, 等.阿托伐他汀对大鼠缺血心肌TRAIL表达及细胞凋亡的影响[J].温州医学院学报, 2012, 42 (4) :317-321.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(03),360-364 DOI:10.3969/j.issn.1008-0074.2019.03.25            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>复方丹参滴丸联合阿托伐他汀治疗冠心病并高脂血症的疗效及对血清</b>TRAIL<b>的影响</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%BC%A0%E6%B5%B7%E9%BE%99&amp;code=37603903&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">张海龙</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E8%B5%B5%E5%AE%9D%E6%88%90&amp;code=41180408&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">赵宝成</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E5%88%98%E8%82%B2%E9%B9%8F&amp;code=41180409&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">刘育鹏</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E4%B8%AD%E5%A4%AE%E5%86%9B%E5%A7%94%E6%94%BF%E6%B2%BB%E5%B7%A5%E4%BD%9C%E9%83%A8%E6%9C%BA%E5%85%B3%E9%97%A8%E8%AF%8A%E9%83%A8&amp;code=0126469&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">中央军委政治工作部机关门诊部</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:探讨复方丹参滴丸联合阿托伐他汀治疗冠心病并高脂血症的疗效及对血清肿瘤坏死因子相关凋亡诱导配体 (TRAIL) 的影响。<b>方法</b>:收集我院的冠心病合并高脂血症患者109例。随机分为阿托伐他汀组 (57例) 和联合治疗组 (52例, 阿托伐他汀联合复方丹参滴丸治疗) , 疗程3个月, 检测治疗前后的心功能、血脂、血清肿瘤坏死因子 (TNF-α) 、TRAIL水平及生活质量。<b>结果</b>:与治疗前比较, 治疗后两组心功能和血脂水平均有显著改善, 血清TNF-α和TRAIL水平均显著降低 (<i>P</i>均=0.001) ;且与阿托伐他汀组比较, 联合治疗组治疗后心排血量[ (4.1±0.8) L/min比 (4.9±0.6) L/min]、心脏指数[ (3.9±0.6) L·min<sup>-1</sup>·m<sup>-2</sup>比 (4.2±0.7) L·min<sup>-1</sup>·m<sup>-2</sup>]、左室射血分数[ (52.4±1.6) %比 (59.6±1.5) %]、血清高密度脂蛋白-胆固醇[ (1.5±0.4) mmol/L比 (1.9±0.5) mmol/L]水平及生活质量[ (6.2±0.8) 分比 (7.1±1.1) 分]均显著提高, 左室舒张末期内径[ (5.4±0.6) cm比 (5.0±0.7) cm]、血清总胆固醇[ (4.1±0.7) mmol/L比 (3.7±0.9) mmol/L]、甘油三酯[ (1.4±0.6) mmol/L比 (1.1±0.5) mmol/L]、低密度脂蛋白-胆固醇[ (2.9±0.8) mmol/L比 (2.4±0.8) mmol/L]、TNF-α[ (52.1±12.6) ng/L比 (41.3±14.2) ng/L]和TRAIL [ (44.7±24.1) pg/ml比 (34.1±26.6) pg/ml]水平显著降低 (<i>P</i>&lt;0.05或&lt;0.01) 。<b>结论</b>:复方丹参滴丸联合阿伐他汀治疗冠心病并高脂血症患者, 可显著改善心功能、降低血脂水平, 提高生活质量。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%86%A0%E5%BF%83%E7%97%85&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">冠心病;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E9%AB%98%E8%84%82%E8%A1%80%E7%97%87&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">高脂血症;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E4%B8%B9%E5%8F%82&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">丹参;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E9%98%BF%E6%89%98%E4%BC%90%E4%BB%96%E6%B1%80&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">阿托伐他汀;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                                            </p>
                                    <p><b>收稿日期：</b>2018-05-18</p>

            </div>
                    <h1>Therapeutic effect of compound Danshen dripping pills combined atorvastatin on coronary heart disease complicated hyperlipidemia and its influence on serum TRAIL level</h1>
                    <h2>
                    <span>ZHANG Hai-long</span>
                    <span>ZHAO Bao-cheng</span>
                    <span>LIU Yu-peng</span>
            </h2>
                    <h2>
                    <span>Institutional Department of Inpatient, Central Military Commission Political Work Department</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>: To explore therapeutic effect of compound Danshen dripping pills combined atorvastatin on coronary heart disease (CHD) complicated hyperlipidemia and its influence on serum level of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) . <b>Methods</b>:A total of 109 CHD patients with hyperlipidemia treated in our department of cardiology were collected, randomly divided into atorvastatin group (n=57) and combined treatment group (n=52, received atorvastatin combined compound Danshen dripping pills) , both groups were continuously treated for three months. Cardiac function, levels of blood lipids, serum tumor necrosis factor (TNF) -α, TRAIL and quality of life (QOL) were measured and compared between two groups before and after treatment. <b>Results</b>:Compared with before treatment, there were significant improvements in cardiac function and blood lipid levels, and significant reductions in serum levels of TNF-α and TRAIL in two groups after treatment, <i>P</i>=0.001 all; compared with atorvastatin group after treatment, there were significant rise in cardiac output [ (4.1±0.8) L/min vs. (4.9±0.6) L/min], cardiac index [ (3.9±0.6) L·min<sup>-1</sup>·m<sup>-2</sup> vs. (4.2±0.7) L·min<sup>-1</sup>·m<sup>-2</sup>], LVEF [ (52.4±1.6) % vs. (59.6±1.5) %], serum HDL-C [ (1.5±0.4) mmol/L vs. (1.9±0.5) mmol/L]and QOL [ (6.2±0.8) scores vs. (7.1±1.1) scores], and significant reductions in LVEDd [ (5.4±0.6) cm vs. (5.0±0.7) cm], serum levels of TC [ (4.1±0.7) mmol/L vs. (3.7±0.9) mmol/L], TG [ (1.4±0.6) mmol/L vs. (1.1±0.5) mmol/L], LDL-C [ (2.9±0.8) mmol/L vs. (2.4±0.8) mmol/L], TNF-α[ (52.1±12.6) ng/L vs. (41.3±14.2) ng/L]and TRAIL [ (44.7±24.1) pg/ml vs. (34.1±26.6) pg/ml]in combined treatment group, <i>P</i>&lt;0.05 or &lt;0.01. <b>Conclusion</b>:Compound Danshen dripping pills combined atorvastatin can significantly improve heart function, reduce blood lipid levels and improve quality of life in CHD patients with hyperlipidemia.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Coronary%20disease&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Coronary disease;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Hyperlipidemias&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Hyperlipidemias;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Salvia%20miltiorrhiza&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Salvia miltiorrhiza;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Atorvastatin&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Atorvastatin;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                                            </p>
                                    <p><b>Received：</b> 2018-05-18</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="47">冠心病 (CHD) 患者多存在着高脂血症, 高脂血症不仅与动脉粥样硬化的发生发展密切相关, 同时在冠状动脉综合征发病过程起重要作用, 加强冠心病患者高脂血症防治极其重要。复方丹参滴丸常联合他汀类药物治疗冠心病合并高脂血症并获得较好的效果, 但其机制尚不完全明晰<citation id="84" type="reference"><link href="5" rel="bibliography" /><link href="7" rel="bibliography" /><link href="9" rel="bibliography" /><sup>[<a class="sup">1</a>,<a class="sup">2</a>,<a class="sup">3</a>]</sup></citation>。目前认为肿瘤坏死因子相关凋亡诱导配体 (Tumor necrosis factor-related apoptosis-inducing ligand, TRAIL) 在冠心病合并高脂血症具有调节细胞凋亡作用<citation id="85" type="reference"><link href="11" rel="bibliography" /><link href="13" rel="bibliography" /><sup>[<a class="sup">4</a>,<a class="sup">5</a>]</sup></citation>。本研究拟考察复方丹参滴丸联合阿托伐他汀治疗冠心病合并高脂血症的效果及对外周血TRAIL水平影响, 为复方丹参滴丸联合阿托伐他汀的临床应用提供理论依据。</p>
                </div>
                <h3 id="48" name="48" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="49" name="49">1.1 研究对象</h4>
                <div class="p1">
                    <p id="50">经院内伦理委员会同意, 收集 2014 年3 月～2016年10 月在我院心内科就诊且符合 WHO 关于冠心病及高脂血症的诊断标准的冠心病合并高脂血症患者109例。随机分为阿托伐他汀组和联合治疗组, 分别为57例和52例, 阿托伐他汀组患者年龄52～89 (67.5±7.6) 岁, 男26例, 女21例;联合治疗组患者年龄53～87 (65.8±9.7) 岁, 男 27例, 女25例。两组患者年龄、性别等一般资料差异无统计学意义, 具有可比性。排除标准:合并严重的心、肝、肺和肾功能障碍者;存在心力衰竭、急性心肌梗死病史、脑卒中史者;精神功能障碍, 难以自由表达和交流者;妊娠或哺乳期女性。</p>
                </div>
                <h4 class="anchor-tag" id="51" name="51">1.2 治疗</h4>
                <div class="p1">
                    <p id="52">阿托伐他汀组:给予阿托代他汀 (国药准字 J20120050, 规格:10mg/片, Pfizer Ireland Pharmaceuticals) 治疗, 每晚口服1片, 连续治疗3个月。联合治疗组在阿托伐他汀组基础上给予复方丹参滴丸 (国药准字:Z10950111, 规格:27mg/丸, 天津天士力制药股份有限公司) , 1丸/次, 2次/d, 连续治疗3个月。</p>
                </div>
                <h4 class="anchor-tag" id="53" name="53">1.3 指标检测</h4>
                <h4 class="anchor-tag" id="54" name="54">1.3.1 心功能参数:</h4>
                <div class="p1">
                    <p id="55">采用iE3超声心动图 (美国飞利浦philips公司) 测定所有患者治疗前后有的心排血量、左室舒张末内径、心脏指数和左室射血分数。</p>
                </div>
                <h4 class="anchor-tag" id="56" name="56">1.3.2 血脂参数:</h4>
                <div class="p1">
                    <p id="57">采用BS-330E全自动生化分析仪 (深圳迈瑞生物医疗电子股份有限公司) 检测所有患者治疗前后空腹外周血的血脂水平。于清晨空腹所有患者5 ml静脉血, 置于抗凝试管内, 分离血浆, 采用酶比色法检测总胆固醇 (TC) 、甘油三酯 (TG) 、 高密度脂蛋白-胆固醇 (HDL-C) 、低密度脂蛋白-胆固醇 (LDL-C) 。TC、TG、HDL-C和LDL-C试剂盒均由南京建成生物工程研究所提供。</p>
                </div>
                <h4 class="anchor-tag" id="58" name="58">1.3.3 血清肿瘤坏死因子 (TNF-α) 和TRAIL:</h4>
                <div class="p1">
                    <p id="59">采用MRX型酶标仪 (美国 Dynex 公司) 以酶联免疫吸附法检测外周血血清TRAIL和TNF-α的含量, 试剂盒均由上海森雄科技实业有限公司提供。</p>
                </div>
                <h4 class="anchor-tag" id="60" name="60">1.3.4 生活质量评定:</h4>
                <div class="p1">
                    <p id="61">采用Spitzer指数评定生活质量, 包括活动能力、日常生活、健康感受、生活感受和家庭支持, 分数越高, 生活质量也越高。</p>
                </div>
                <h4 class="anchor-tag" id="62" name="62">1.4 统计学处理</h4>
                <div class="p1">
                    <p id="63">采用SPSS 20.0软件进行统计分析, 计量资料以均数±标准差<mathml id="64"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml>表示, 比较采用<i>t</i>检验, 计数资料以百分率表示, 比较采用<i>χ</i><sup>2</sup>检验。<i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <h3 id="65" name="65" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="66" name="66">2.1 两组治疗前后心功能比较</h4>
                <div class="p1">
                    <p id="67">两组治疗前心排血量、左室舒张末期内径、心脏指数和左室射血分数均无统计学差异 (<i>P</i>均&gt;0.05) , 治疗后, 两组的心排血量、心脏指数和左室射血分数显著增加, 左室舒张末期内径显著减小 (<i>P</i>均=0.001) ;与阿托伐他汀组比较, 联合治疗组的心排血量、心脏指数和左室射血分数显著增加, 左室舒张末期内径显著减小 (<i>P</i>&lt;0.05或&lt;0.01) , 见表1。</p>
                </div>
                <h4 class="anchor-tag" id="68" name="68">2.2 两组治疗前后的血脂水平比较</h4>
                <div class="p1">
                    <p id="69">两组治疗前血脂水平比较无统计学差异 (<i>P</i>均&gt;0.05) , 治疗后, 两组清TC、TG和LDL-C水平显著降低, HDL-C水平显著升高 (<i>P</i>均&lt;0.01) , 与阿托伐他汀组比, 联合治疗组血清TC、TG和LDL-C水平显著降低, HDL-C水平显著升高 (<i>P</i>&lt;0.05或&lt;0.01) , 见表2。</p>
                </div>
                <div class="area_img" id="70">
                    <p class="img_tit"><b>表</b>1 <b>两组治疗前后的心功能比较</b><mathml id="71"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="70" border="1"><tr><td><br />组别</td><td>时间</td><td>心排血量<br /> (L/min) </td><td>左室舒张末期内径<br /> (cm) </td><td>心脏指数<br /> (L·min<sup>-1</sup>·m<sup>-2</sup>) </td><td>左室射血分数<br /> (%) </td></tr><tr><td><br />阿托伐他汀组 (57例) </td><td>治疗前</td><td>2.4±0.7</td><td>6.0±0.5</td><td>3.5±0.5</td><td>42.1±1.3</td></tr><tr><td><br /></td><td>治疗后</td><td>4.1±0.8<sup>**</sup></td><td>5.4±0.6<sup>**</sup></td><td>3.9±0.6<sup>**</sup></td><td>52.4±1.6<sup>**</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>12.074/0.001</td><td>5.800/0.001</td><td>3.867/0.001</td><td>37.721/0.001</td></tr><tr><td><br />联合治疗组 (52例) </td><td>治疗前</td><td>2.5±0.9</td><td>5.9±0.6</td><td>3.6±0.6</td><td>41.7±1.2</td></tr><tr><td><br /></td><td>治疗后</td><td>4.9±0.6<sup>**△△</sup></td><td>5.0±0.7<sup>**△△</sup></td><td>4.2±0.7<sup>**△</sup></td><td>59.6±1.5<sup>**△△</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>16.001/0.001</td><td>7.039/0.001</td><td>4.693/0.001</td><td>67.196/0.001</td></tr><tr><td><br />组间治疗前<i>t</i>/<i>P</i></td><td></td><td>0.651/0.518</td><td>0.948/0.347</td><td>0.948/0.347</td><td>1.664/0.102</td></tr><tr><td><br />组间治疗后<i>t</i>/<i>P</i></td><td></td><td>5.861/0.001</td><td>3.211/0.002</td><td>2.408/0.020</td><td>24.174/0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:与治疗前比较*<i>P</i>&lt;0.05, **<i>P</i>&lt;0.01;与阿托伐他汀组比△<i>P</i>&lt;0.05, △△<i>P</i>&lt;0.01;。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <div class="area_img" id="72">
                    <p class="img_tit"><b>表</b>2 <b>两组治疗前后的血脂水平比较</b><mathml id="73"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false"> (</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">) </mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="72" border="1"><tr><td><br />组别</td><td>时间</td><td>总胆固醇<br /> (mmol/L) </td><td>甘油三酯<br /> (mmol/L) </td><td>高密度脂蛋白-胆固醇<br /> (mmol/L) </td><td>低密度脂蛋白-胆固醇<br /> (mmol/L) </td></tr><tr><td><br />阿托伐他汀组 (57例) </td><td>治疗前</td><td>5.2±0.7</td><td>2.0±0.5</td><td>1.3±0.3</td><td>3.7±0.9</td></tr><tr><td><br /></td><td>治疗后</td><td>4.1±0.7<sup>**</sup></td><td>1.4±0.6<sup>**</sup></td><td>1.5±0.4<sup>**</sup></td><td>2.9±0.8<sup>**</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>8.389/0.001</td><td>5.800/0.001</td><td>3.020/0.004</td><td>5.016/0.001</td></tr><tr><td><br />联合治疗组 (52例) </td><td>治疗前</td><td>5.3±0.8</td><td>2.1±0.7</td><td>1.4±0.5</td><td>3.7±0.7</td></tr><tr><td><br /></td><td>治疗后</td><td>3.7±0.9<sup>**△</sup></td><td>1.1±0.5<sup>**△△</sup></td><td>1.9±0.5<sup>**△△</sup></td><td>2.4±0.8<sup>**△△</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>9.582/0.001</td><td>8.383/0.001</td><td>5.099/0.001</td><td>8.819/0.001</td></tr><tr><td><br />组间治疗前<i>t</i>/<i>P</i></td><td></td><td>0.696/0.490</td><td>0.864/0.392</td><td>1.279/0.207</td><td>0.001/0.999</td></tr><tr><td><br />组间治疗后<i>t</i>/<i>P</i></td><td></td><td>2.602/0.012</td><td>2.821/0.007</td><td>4.631/0.001</td><td>3.259/0.002</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="74" name="74">2.3 两组治疗前后的血清TNF-α、TRAIL水平及生活质量比较</h4>
                <div class="p1">
                    <p id="75">两组治疗前的TNF-α、TRAIL水平及生活质量均无统计学差异 (<i>P</i>均&gt;0.05) , 治疗后, 两组的TNF-α、TRAIL水平均显著降低, 生活质量显著提高 (<i>P</i>均=0.001) , 与阿托伐他汀组比, 联合治疗组的TNF-α、TRAIL水平显著降低, 生活质量显著提高 (<i>P</i>&lt;0.05或&lt;0.01) , 见表3。</p>
                </div>
                <div class="area_img" id="76">
                    <p class="img_tit"><b>表</b>3 <b>两组治疗前后</b>TNF-α、TRAIL<b>水平和生活质量比较</b> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="76" border="1"><tr><td>组别</td><td></td><td>TNF-α</td><td>TRAIL<br /> (pg/ml) </td><td>生活质量<br /> (分) </td></tr><tr><td><br />阿托伐他汀<br />组 (57例) </td><td>治疗前</td><td>60.6±11.5</td><td>62.4±12.3</td><td>5.2±0.9</td></tr><tr><td><br /></td><td>治疗后</td><td>52.1±12.6<sup>**</sup></td><td>44.7±24.1<sup>**</sup></td><td>6.2±0.8<sup>**</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>3.762/0.001</td><td>4.939/0.001</td><td>6.270/0.001</td></tr><tr><td><br />联合治疗组<br /> (52例) </td><td>治疗前</td><td>61.2±13.3</td><td>62.9±13.5</td><td>5.3±1.0</td></tr><tr><td><br /></td><td>治疗后</td><td>41.3±14.2<sup>**△△</sup></td><td>34.1±26.6<sup>**△</sup></td><td>7.1±1.1<sup>**△△</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>7.376/0.001</td><td>6.962/0.001</td><td>8.731/0.001</td></tr><tr><td><br />组间治疗前<i>t</i>/<i>P</i></td><td></td><td>0.253/0.802</td><td>0.202/0.840</td><td>0.550/0.585</td></tr><tr><td><br />组间治疗后<i>t</i>/<i>P</i></td><td></td><td>4.207/0.001</td><td>2.183/0.034</td><td>4.915/0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:TNF-α:肿瘤坏死因子, TRAIL:肿瘤坏死因子相关凋亡诱导配体。</p>
                    <p class="img_note"></p>
                </div>
                <h3 id="77" name="77" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="78">冠心病的发病机理在于动脉粥样硬化, 致使动脉粥样硬化的根本在于血脂代谢异常与紊乱, 因此冠心病患者常伴有高脂血症, 而高血脂可加重冠心病的发展, 即动脉腔狭窄, 血流不畅, 影响到心脏的缺血缺氧, 出现心绞痛、心肌梗死等一系列心血管不良事件, 降低了患者生存质量, 严重者可威胁生命, 因此给予积极治疗也十分紧迫<citation id="86" type="reference"><link href="15" rel="bibliography" /><link href="17" rel="bibliography" /><sup>[<a class="sup">6</a>,<a class="sup">7</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="79">阿托伐他汀归属他汀类药物, 也是3-羟基-3-甲基戊二酰辅酶A (HMG-CoA) 还原酶抑制剂, 阿托伐他汀通过抑制HMG-CoA还原酶, 抑制低密度脂蛋白的生成, 促进低密度脂蛋白向细胞内的转入, 有效清除和降低胞内胆固醇水平, 达到控制血脂的目的。本课题结果显示, 阿托伐他汀组患者血脂水平显著改善, 说明阿托伐他汀可有效控制血脂<citation id="87" type="reference"><link href="19" rel="bibliography" /><link href="21" rel="bibliography" /><link href="23" rel="bibliography" /><sup>[<a class="sup">8</a>,<a class="sup">9</a>,<a class="sup">10</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="80">复方丹参滴丸的成分为丹参、三七和冰片, 具有活血化瘀和消肿止痛的功效, 可用于治疗冠心病心绞痛、神经系统及脑血管并发症。本课题结果显示在阿托伐他汀基础上应用复方丹参滴丸可显著改善冠心病的心功能, 降低血脂水平, 提高生活质量, 与复方丹参滴丸的成分的药理效应密切相关<citation id="88" type="reference"><link href="25" rel="bibliography" /><link href="27" rel="bibliography" /><link href="29" rel="bibliography" /><sup>[<a class="sup">11</a>,<a class="sup">12</a>,<a class="sup">13</a>]</sup></citation>: (1) 丹参具有扩张血管、改善微循环、增加动脉血流量、减轻缺血引起的细胞膜及线粒体膜损伤、提高红细胞变形能力、减少红细胞破裂、抑制血小板聚集, 抗凝和降低血液黏稠度的作用; (2) 三七具有降低动脉血压、增加冠脉血流和降低心肌耗氧的作用; (3) 冰片具有抗炎镇痛作用; (4) 丹参与三七中的三七总甙可协同提高超氧化物歧化酶 (SOD) 活性, 抑制血清脂质过氧化物合成, 降低氧自由基水平。</p>
                </div>
                <div class="p1">
                    <p id="81">TRAIL在结构上属于TNF-α超家族成员, TRAIL具有4个跨膜蛋白受体, 与TRAIL结合后可诱导死亡, 提示TRAIL 不是直接诱导细胞凋亡的, 而是通过受体表达来间接调控的。生理条件下, TRAIL对正常细胞不存在显著的促凋亡作用, 但在炎症和缺氧等病理状态下, TRAIL可诱导细胞凋亡, 如在风湿性关节炎患者关节可见TRAIL大量表达, 与诱导破骨细胞凋亡关系紧密, 心肌梗死发生时, 外周血的TRAIL可表达上调并介导缺血相关的细胞凋亡, 甚至在原位即可导致细胞凋亡, 机理在于在细胞凋亡的级联反应中, TRAIL可以活化下游caspase3, 启动细胞凋亡, TRAIL的表达水平与细胞凋亡数目呈正相关关系, 如急性脑梗死患者血清TRAIL水平与梗死面积相关<citation id="89" type="reference"><link href="31" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>;另外还有报道补充认为TRAIL可起到类似血管内皮生长因子的作用, 当给予外源性TRAIL可以促进血管内皮细胞增生移行, 有助于血管新生<citation id="90" type="reference"><link href="33" rel="bibliography" /><sup>[<a class="sup">15</a>]</sup></citation>。本课题结果显示, 给予阿托伐他汀治疗, 不仅显著降低患者外周血TNF-α水平, 还显著降低TRAIL水平, 提示阿托伐他汀除了调脂功效外还具有抑制炎症作用。在阿托伐他汀基础上给予复方丹参滴丸, 可进一步降低冠心病合并高血脂症患者外周血的TNF-α和TRAIL水平, 可见复方丹参滴丸也具有降低TNF-α和TRAIL水平的作用。研究也显示含有丹参的凉血活血方可通过降低血浆和腹水的TRAIL水平达到防治术后腹腔粘连的效果<citation id="91" type="reference"><link href="35" rel="bibliography" /><sup>[<a class="sup">16</a>]</sup></citation>, 含有三七总皂苷的注射用血栓可通过下调Caspase-3表达来抑制TRAIL诱导的血管内皮细胞凋亡, 进而改善心功能<citation id="92" type="reference"><link href="37" rel="bibliography" /><link href="39" rel="bibliography" /><sup>[<a class="sup">17</a>,<a class="sup">18</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="82">但也有研究显示, 急性心肌梗死后心肌TRAIL水平较假手术组显著降低, 给予阿托伐他汀治疗, 缺血心肌TRAIL水平升高<citation id="93" type="reference"><link href="41" rel="bibliography" /><sup>[<a class="sup">19</a>]</sup></citation>, 或有研究认为急性心肌梗死后早期血清 TRAIL水平显著降低, 随后升高, 半年后可恢复至正常水平<citation id="94" type="reference"><link href="43" rel="bibliography" /><sup>[<a class="sup">20</a>]</sup></citation>。以上结果是否提示TRAIL在缺血或炎性相关疾病的作用较复杂, 既有促凋亡作用, 也有抗凋亡作用, 如TRAIL及TRAIL相关受体可促进包括淋巴细胞、内皮细胞、血管平滑肌细胞和成纤维细胞等多种细胞的存活和增殖<citation id="95" type="reference"><link href="45" rel="bibliography" /><sup>[<a class="sup">21</a>]</sup></citation>, 倘若以上检测不因为纳入案例有限而出现偏差, 那么如平衡TRAIL水平, TRAIL 能否作为一种治疗冠心病合并高血脂症的靶点及如何利用TRAIL来制定治疗方案, 仍需要进一步分析考察。</p>
                </div>
                <div class="p1">
                    <p id="83">综上所述, 复方丹参滴丸联合阿伐他汀治疗冠心病合并高脂血症患者, 不仅可显著改善患者心功能、降低血脂水平, 还可提高生活质量, 可能与降低外周血TRAIL有关。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYYY201202013&amp;v=MDU5MjFyQ1VSN3FmWnVabUZ5amxWTHpJUHpUU2Q3RzRIOVBNclk5RVo0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0Y=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>朱春频.他汀类药物治疗冠心病合并高脂血症的效果分析[J].中西医结合心脑血管病杂志, 2012, 10 (2) :144.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=LZBJ201505013&amp;v=MTM5Mzc0UUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTHpJS1RmSlpMRzRIOVRNcW85RVo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>王丽美, 许军芳, 陈文静, 王锐霞, 张娜.复方丹参滴丸联合阿托伐他汀治疗冠心病并高脂血症的疗效分析[J].中国临床保健杂志, 2015, 14 (5) :489-492.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=WMIA201524109&amp;v=MjMxNTlJTWlEQ2I3RzRIOVRPcTQ1RmJZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTHo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>彭艳.复方丹参滴丸联合瑞舒伐他汀治疗冠心病合并高脂血症患者的临床疗效[J].世界最新医学信息文摘, 2015, 15 (24) :138-139.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CDFD&amp;filename=1014310240.nh&amp;v=MDI0ODFIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZMeklWRjI2R3JDNUh0UElyNUViUElRS0Q=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b>刘芳芳.肿瘤坏死因子相关凋亡诱导配体及其受体DR5对动脉粥样硬化斑块形成的影响[D].济南:山东大学, 2014.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGYX201502015&amp;v=MDE2NzlJUHlyU2RyRzRIOVRNclk5RVlZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5amxWTHo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b>齐玲, 赵东海, 王玮瑶, 等.Caspase-8和Bcl-2在脑肿瘤干细胞肿瘤坏死因子相关凋亡诱导配体耐药中的作用研究[J].中国药学杂志, 2015, 50 (2) :152-156.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZWYY201310060&amp;v=MDY5MTVEWklRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZMeklQenJTZDdHNEg5TE5yNDk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[6]</b>钱茜.阿托伐他汀治疗老年冠心病合并高脂血症临床研究[J].中国现代药物应用, 2013, 7 (10) :72-73.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGUD201315035&amp;v=MzE4NTFtRnlqbFZMeklQeXJlYXJHNEg5TE5xbzlHWVlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[7]</b>宋勇宏.阿托伐他汀在老年冠心病合并高脂血症中的应用分析[J].中国当代医药, 2013, 20 (15) :65-66.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XDZD201303110&amp;v=MzE3NzE0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpsVkx6SVBTblJhckc0SDlMTXJJNUVaSVFLREg4NHZSNFQ2ajU=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b>吴法令.阿托伐他汀治疗老年冠心病合并高脂血症的临床分析[J].现代诊断与治疗, 2013, 24 (3) :627-628.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" >
                                    <b>[9]</b>
                                陈树彤, 史培杰, 黄电波, 等.复方丹参滴丸治疗冠心病合并高脂血症疗效观察[C].复方丹参滴丸美国FDAII期临床试验结果报告暨第四届学术研讨会论文集.2010:183-185.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YXLL201213022&amp;v=MjA2NzE0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpsVkx6SVBEWEhZckc0SDlQTnJJOUhab1FLREg4NHZSNFQ2ajU=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>刘清安.辛伐他汀 (舒降之) 联合复方丹参滴丸治疗冠心病合并高脂血症102例临床分析[J].医学理论与实践, 2012, 25 (13) :1583-1584.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PZXX201401045&amp;v=MjI4ODVSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpsVkx6SU5UZlRkckc0SDlYTXJvOUJZWVFLREg4NHY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>许玲.复方丹参滴丸联合瑞舒伐他汀治疗冠心病合并高脂血症患者的临床疗效[J].中国循证心血管医学杂志, 2014, 7 (1) :99-101.
                            </a>
                        </p>
                        <p id="27">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGUD201308064&amp;v=MjYyODZHNEg5TE1wNDlEWUlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZMeklQeXJlYXI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b>纪佳.复方丹参滴丸对高血脂患者血液流变学的影响[J].中国当代医药, 2013, 6 (8) :117-118, 120.
                            </a>
                        </p>
                        <p id="29">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SLYY201301032&amp;v=MjI2MTJGeWpsVkx6SU5pSFNkN0c0SDlMTXJvOUdab1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm0=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b>林大梁, 林先锋, 袁小兰.复方丹参滴丸治疗冠心病的临床分析[J].数理医药学杂志, 2013, 26 (1) :82-83.
                            </a>
                        </p>
                        <p id="31">
                            <a id="bibliography_14" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=KDYZ200711011&amp;v=MTg3NjU3cWZadVptRnlqbFZMeklMaW5TZExHNEh0Yk5ybzlFWllRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[14]</b>任满意, 张运, 隋树建, 等.肿瘤坏死因子相关的凋亡诱导配体及其死亡受体5与急性冠状动脉综合征的关系[J].中国动脉硬化杂志, 2007, 15 (11) :842-846.
                            </a>
                        </p>
                        <p id="33">
                            <a id="bibliography_15" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CMFD&amp;filename=1011142646.nh&amp;v=MTE2MDI4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpsVkx6SVZGMjZIN0s4SE5mSXFaRWJQSVFLREg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[15]</b>刘利宁.急性脑梗死患者血清TRAIL、OPG测定及其临床意义的研究[D].兰州:兰州大学, 2011.
                            </a>
                        </p>
                        <p id="35">
                            <a id="bibliography_16" >
                                    <b>[16]</b>
                                白景瑞.清热解毒方与凉血活血方防治术后腹腔粘连的实验研究[D].天津:天津医科大学, 2016.
                            </a>
                        </p>
                        <p id="37">
                            <a id="bibliography_17" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=BXYY201007059&amp;v=MDA2MDk5SE1xSTlBYllRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqbFZMeklKelhTZDdHNEg=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[17]</b>李响, 吴振起, 马雪涛, 等.注射用血栓通对大鼠血管内皮细胞凋亡机制的影响[J].中华中医药杂志, 2010, 25 (7) :1137-1139.
                            </a>
                        </p>
                        <p id="39">
                            <a id="bibliography_18" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYJZ201412095&amp;v=MTk5ODF6VEJkTEc0SDlYTnJZOU1ZWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpsVkx6SVA=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[18]</b>华新宇, 王晓兰, 康美清, 等.三七总皂苷对慢性心力衰竭患者心功能及血浆细胞凋亡相关因子的影响[J].中国中医急症, 2014, 23 (12) :2368-2370.
                            </a>
                        </p>
                        <p id="41">
                            <a id="bibliography_19" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES13011601333593&amp;v=MjQ1NjUrZ01DWFU2b0JNVDZUNFBRSC9pclJkR2VycVFUTW53WmVadEZpbmxVcmZJSUY0VGFSST1OaWZPZmJLN0h0RE5xWTlFWg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[19]</b>Schoppet M, Sattler AM, Schaefer JR, et al.Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis[J].Atherosclerosis, 2006, 184 (2) :446-447.
                            </a>
                        </p>
                        <p id="43">
                            <a id="bibliography_20" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt">

                                <b>[20]</b>Morel J, Audo R, Hahne M, et al.Tumor necrosis factor related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol3kinase/Akt[J].J Biol Chem, 2005, 280 (16) :15709-15718.
                            </a>
                        </p>
                        <p id="45">
                            <a id="bibliography_21" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=WZYX201204005&amp;v=MDI4NTZxQnRHRnJDVVI3cWZadVptRnlqbFZMeklNamZTZHJHNEg5UE1xNDlGWVlRS0RIODR2UjRUNmo1NE8zenE=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[21]</b>王素云, 王海芸, 黄晓燕, 等.阿托伐他汀对大鼠缺血心肌TRAIL表达及细胞凋亡的影响[J].温州医学院学报, 2012, 42 (4) :317-321.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201903026" />
        <input id="dpi" type="hidden" value="200" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201903026&amp;v=MDkzNTRqbFZMeklQVFhNWmJHNEg5ak1ySTlIWW9RS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnk=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
